The effect of fluticasone propionate on respiratory syncytial virus-induced chemokine release by a human bronchial epithelial cell line

Immunopharmacology

Volumn 39, Issue 3, 1998, Pages 193-199

  Noah, Terry L ^a   Wortman, Ivo A ^a   Becker, Susanne ^b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

Asthma; Chemokine; Corticosteroid; Fluticasone propionate; IL 8; RANTES; Respiratory syncytial virus

Indexed keywords

CHEMOKINE; FLUTICASONE PROPIONATE; INTERLEUKIN 8; RANTES;

ARTICLE; BRONCHUS MUCOSA; EPITHELIUM CELL; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; RESPIRATORY SYNCYTIAL PNEUMOVIRUS;

ANDROSTADIENES; ANTI-INFLAMMATORY AGENTS; BRONCHI; CELL LINE; EPITHELIAL CELLS; HUMANS; INTERLEUKIN-8; RANTES; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN;

EID: 0032097891     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-3109(98)00017-4     Document Type: Article

References (28)

1. Adcock I.et al. Glucocorticoid receptor localization in normal and asthmatic lung. Am. J. Respir. Crit. Care Med. 154:1996;771-782.
2. Alam R.et al. RANTES is a chemotactic and activating factor for human eosinophils. J. Immunol. 150:1993;3442-3447.
3. Becker S.et al. IL-8 expression in normal nasal epithelium and its modulation by infection with respiratory syncytial virus and cytokines TNF, IL-1, and IL-6. Am. J. Respir. Cell. Mol. Biol. 8:1992;20-27.
4. Becker S.et al. RSV infection of human airway epithelial cells causes production of the β-chemokine RANTES. Am. J. Physiol. 272:1997;L512-L520.
5. Busse W. Respiratory infections: their role in airway responsiveness and the pathogenesis of asthma. J. Allergy Clin. Immunol. 85:1990;671-683.
6. Denny F., Clyde W. Acute lower respiratory tract infections in non-hospitalized children. J. Pediatr. 108:1986;635-646.
7. Fiedler M.et al. Respiratory syncytial virus increases IL-8 gene expression and protein release in A549 cells. Am. J. Physiol. 269:1995;L865-L872.
8. Hoch R.et al. In vivo, in vitro, and molecular aspects of interleukin-8 and the interleukin-8 receptors. J. Lab. Clin. Med. 128:1996;134-145.
9. Hoekstra M.et al. Fluticasone propionate in children with moderate asthma. Am. J. Respir. Crit. Care Med. 154:1996;1039-1044.
10. Holliday S.et al. Inhaled fluticasone propionate: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in asthma. Drugs. 47:1994;318-331.
11. Ke Y.et al. Human bronchial epithelial cells with integrated SV40 virus T antigen genes retain the ability to undergo squamous differentiation. Differentiation. 38:1988;60-66.
12. Korn S.et al. In vitro and in vivo modulation of α- and β-glucocorticoid receptor mRNA in human bronchial epithelium. Am. J. Respir. Crit. Care Med. 155:1997;1117-1122.
13. Kwon O.et al. Tumor necrosis factor-induced interleukin-8 expression in cultured human airway cells. Am. J. Physiol. 267:1994;L398-L405.
14. Kwon O.et al. Glucocorticoid inhibition of RANTES expression in human lung epithelial cells. Am. J. Respir. Cell. Mol. Biol. 12:1995;488-496.
15. Lemanske R.et al. Rhinovirus upper respiratory infection increases airway hyperreactivity and late asthmatic reactions. J. Clin. Invest. 83:1989;1-10.
16. Mastronarde J.et al. Oxidant tone regulates IL-8 production in epithelium infected with respiratory syncytial virus. Am. J. Respir. Cell. Mol. Biol. 13:1995;237-244.
17. Nicholson K.et al. Respiratory viruses and exacerbations of asthma in adults. BMJ. 307:1993;982-986.
18. Noah T., Becker S. Respiratory syncytial virus-induced cytokine production by a human bronchial epithelial cell line. Am. J. Physiol. 265(9):1993;L472-L478.
19. Noah T.et al. Nasal cytokine production in viral acute upper respiratory infection of childhood. J. Infect. Dis. 171:1995;584-592.
20. Noah T.et al. Cytokine production by human bronchial epithelial cells infected with an adenoviral gene therapy vector or wild-type adenovirus type 5. Am. J. Respir. Cell. Mol. Biol. 14:1996;417-424.
21. Reddel R.et al. Transformation of human bronchial epithelial cells by infection with SV40 or adenovirus-12 SV40 hybrid virus, or transformation via strontium phosphate coprecipitation with a plasmid containing SV40 early region gene. Cancer Res. 48:1988;1904-1909.
22. Saito T.et al. Respiratory syncytial virus induces selective production of the chemokine RANTES by upper airway epithelial cells. J. Infect. Dis. 175:1997;497-504.
23. Schall T.et al. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature. 347:1990;669-671.
24. Springer C., Bar-Yishay E., Uwayyed K., Avital A., Vilozni D., Godfrey S. Corticosteroids do not affect the clinical or physiological status of infants with bronchiolitis. Pediatr. Pulmonol. 9:1990;181-185.
25. Stellato C.et al. Expression of the chemokine RANTES by a human bronchial epithelial cell line. Modulation by cytokines and glucocorticoids. J. Immunol. 155:1995;410-418.
26. Subauste M.et al. Infection of a human respiratory epithelial cell line with rhinovirus. Induction of cytokine release and modulation of susceptibility to infection by cytokine exposure. J. Clin. Invest. 96:1995;549-557.
27. van Essen-Zandvliet E.et al. Effects of 22 months of treatment with inhaled corticosteroids and/or β-2-agonists on lung function, airway responsiveness, and symptoms in children with asthma. Am. Rev. Respir. Dis. 146:1992;547-554.
28. Zinserling A. Peculiarities of lesions in viral and mycoplasma infections of the respiratory tract. Virchows. Arch. Abt. A: Pathol. Anat. 356:1972;259-273.